Lifestyle-related Factors And Burden Of Cardiovascular Diseases In Japan | 41377
Journal of Community Medicine & Health Education
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The Global Burden of Disease Study showed that the years of life lost due to stroke and coronary heart disease were the
highest in Japan in 2010. The high morbidity and mortality noted in the Japanese population were given significant cost
to the society. Cardiovascular diseases share risk factors with other major non-communicable diseases, including tobacco
smoking, unhealthy diet, physical inactivity, history of diabetes, metabolic factors (hypertension, high serum glucose, low high
density lipid-cholesterol, hypertriglyceridemia and overweight). The Japan national health and nutrition surveys since 1945
have provided the prominent information for health promotion strategies issued by the health ministry. In Japan, most (63%)
dietary sodium came from soy sauce (20%), commercially processed fish/seafood (15%), salted soups (15%) and preserved
vegetables (13%). The national campaigns for reducing salt intake, together with other hypertension control programs, resulted
in the great reduction of stroke mortality since 1960s. However, because of the westernization of lifestyles such as high-fat
diets and sedentary work patterns associated with socioeconomic development, there has a possible increase in the incidence
of mortality from coronary heart disease in Japan. For instance, the mean BMI increased in Japanese men with an increment
of 0.44 kg/m2 between 1976 and 1995. In 2009, the obesity was 31.7% in men and 21.8% in women aged 20 and above. The
prevalence of high total cholesterol (≥220 mg/d L) increased from 15% to 27% for men and 19% to 35% for women.
Enbo Ma is a public health physician and has a PhD in Epidemiology. Currently he is Assistant Professor, Department of Clinical Trial and Clinical Epidemiology, University of Tsukuba Faculty of Medicine, Japan. He has published some papers on cancer and cardiovascular diseases in medical and public health journals.